Formula E and Google Cloud have recently announced a new multi-year AI and technology partnership which kicked off with the groundbreaking GEN3 Evo era.

The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...

From packable sleeping pads to ultracomfortable air beds, we tested and found the best camping mattresses and sleeping pads ...

This extensive library hosts sets of math problems suitable for students PreK-12. The resources span multiple topics and members have access to the over 1,000 problems and supporting materials! Share ...

Leveraging a roster of innovative technical upgrades, the GEN3 Evo unveiled at H.S.H Prince Albert II’s Private Car Collection will debut in Season 11 of the ABB FIA Formula E World Championship.

Formula E is set to get a lot faster with the introduction of the GEN3 Evo, the quickest accelerating FIA single-seater race car – Capable of 0-60mph in 1.82 seconds (0-100kph in 1.86s). Set to race ...

Sauber has announced it is going to establish a new technical center for its Formula 1 team in the United Kingdom, in addition to its (…) ...